An FDA panel votes to recommend approval of Staar Surgical's Visian Toric implantable collamer lens for treating myopic astigmatism, sending shares up today on Wall Street.
An FDA advisory panel voted last week to recommend approval for Staar Surgical's (NSDQ:STAA) Visian Toric implantable collamer lens for myopic astigmatism, sending STAA shares up nearly 17% today.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1hspJIa
Cap comentari:
Publica un comentari a l'entrada